-
In a prospective observational study, investigators of the HIV-CAUSAL Collaboration evaluated data from participating HIV clinics in Europe and the U.S. Veterans Administration system to determine the optimal CD4+ T cell count at which combination antiretroviral therapy (cART) should be initiated.
-
GARDASIL® (Human Papillomavirus Quadrivalent [Types 6, 11, 16, 18] Vaccine, Recombinant) previously received FDA approval for prevention of cervical, vulvar, and vaginal cancer and associated precancerous lesions, and for prevention of genital warts in males and females 9-26 years of age.
-
A retrospective study was conducted of 563 children who presented over the last decade to two pediatric immunodeficiency centers in the United Kingdom.
-
ZOSTAVAX®, which had previously received FDA approval for prevention of herpes zoster (HZ) and post-herpetic neuralgia in individuals 60 years of age and older, had its approval extended to include people 50-59 years of age on March 24, 2011.
-
Of 150 patients with hematogenous vertebral osteomyelitis, 92 (61%) underwent biopsy 60 (65%) needle and 32 (35%) open. Imaging studies revealed discitis in 75%, vertebral osteomyelitis in 70%, and epidural abscess in 44% of patients.
-
The headlines once again warn of a new superbug threatening mankind.
-
Hospitals should provide pertussis vaccines to their health care workers free of charge, but should still treat employees with antibiotics if they have unprotected exposure to patients with pertussis and work with patients at high risk, such as young infants, a federal vaccine advisory panel says.
-
The Joint Commission has amended an infection control standard that called for hand hygiene compliance of more than 90%, conceding that the expectation was too high after a group of eight leading hospitals could muster only an 82% rate in a performance improvement project.
-
Researchers at Johns Hopkins University School of Medicine have determined that electronic-eye faucets, which presumably lower bacterial hand contamination via hands-free usemay actually endanger high-risk patients with Legionella infection.
-
New Delhi carbapenemase-1 (NDM-1) is increasingly seen in media reports as the organisms that produce metallocarbapenemase, which are most prevalent in South Asia but have now appeared in many parts of the world including the United States.